tirzepatide alzheimer clinical trial Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Lilly Decides to Advance Tirzepatide

The slowing of gastric emptying caused by GLP-1 agonists could theoretically alter alcohol absorption patterns, though this mechanism remains speculative in the context of AUD

The Precision Peptide Genetic Test offered by PlexusDx identifies how your individual genetics influence GLP-1 receptor sensitivity and peptide metabolism, helping your provider optimize single or combined therapies for maximum results

It is important to consult a healthcare professional before making any changes to medication regimens

10.1016/j.jad.2024.11.077 J

Since GLP-1 medications are known to reduce gut motility, scientists have wondered whether they could play a role in causing SIBO or IMO

As the glycolytic pathway is impaired, pyruvate is most likely generated from amino acids such as serine, alanine and cysteine